CurrentAmbetter NevadaPolicy N/A

Sclerotherapy and Chemical Endovenous Ablation for Varicose Veins and Other Symptomatic Venous Disorders

Clinical policy regarding medical necessity guidance for sclerotherapy and chemical endovenous ablation of lower extremity varicose veins and related symptomatic disorders for members of the Health Plan.

Policy Summary

PayerAmbetter Nevada

PolicySclerotherapy and Chemical Endovenous Ablation for Varicose Veins and Other Symptomatic Venous Disorders

Policy CodePolicy N/A

Change TypeNo material clinical or coverage changes

Effective DateN/A

Next Review DateN/A

Key ActionReview applicable NCDs, LCDs, and Medicare Coverage Articles prior to applying the policy and obtain prior authorization as required by the Health Plan.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

2018copyright year

2025latest guideline year

Medicare/Medicaidfederal alignment

Coverage Criteria Overview

Coverage decisions are subject to the terms, conditions, exclusions and limitations set forth in the member's coverage documents (for example, evidence of coverage, certificate of coverage, policy, contract of insurance, etc.). Specific exclusions and limitations that may affect coverage for services described in this clinical policy are contained in those member documents and are not enumerated in this policy.

This clinical policy is a guide to medical necessity and is not medical advice. It does not recommend or mandate specific treatments or substitute for professional clinical judgment; providers remain responsible for diagnosis and treatment decisions for individual members.

The policy was developed by licensed health care professionals after review of current standards of practice, peer-reviewed literature, evidence-based guidelines and other clinical information, but it does not constitute a contract or guarantee of payment or results.

Provider Requirements and Prior Authorization

Prior Authorization

Prior Authorization Recommended

Prior authorization may be required for select procedures described in this clinical policy. Verify the Health Plan's current prior authorization requirements before scheduling services.

Policy Summary

PayerAmbetter Nevada

PolicySclerotherapy and Chemical Endovenous Ablation for Varicose Veins and Other Symptomatic Venous Disorders

Policy CodePolicy N/A

Change TypeNo material clinical or coverage changes

Effective DateN/A

Next Review DateN/A

Key ActionReview applicable NCDs, LCDs, and Medicare Coverage Articles prior to applying the policy and obtain prior authorization as required by the Health Plan.

SourceLink

On This Page

Check payer prior authorization portal for specific requirements and forms.
Confirm member eligibility and benefit limitations prior to service.

Documentation Required

Documentation Requirements

Providers must submit complete and accurate clinical documentation to support medical necessity determinations. Insufficient documentation may result in claim denial or delayed payment.

Include history, physical exam findings, imaging/results, and prior conservative treatment documentation where applicable.
Retain records per contractual and regulatory requirements and provide upon request.

Note

Professional Judgment and Coverage Limitations

This clinical policy is a guide and does not guarantee payment. Coverage decisions and benefit administration remain subject to the member's contract, policy terms, exclusions, and applicable state and federal requirements.

Determine coverage based on the member's specific plan documents (e.g., EOC, policy, contract).
When state Medicaid provisions conflict with this policy, state Medicaid provisions take precedence.

Note

Regulatory Alignment (Medicare/Medicaid)

Review applicable Medicare NCDs, LCDs, and Coverage Articles for Medicare members prior to applying this policy. Legal and regulatory requirements override this clinical policy when discrepancies exist.

Refer to the CMS website at http://www.cms.gov for current NCDs/LCDs.
For Medicaid members, consult the state Medicaid manual when state provisions differ.

Billing Rule

Provider Responsibilities and Billing Rules

Providers are responsible for complying with Health Plan-level administrative policies and billing rules. Unauthorized use or distribution of this clinical policy is prohibited.

Follow plan billing guidelines and submit claims with appropriate CPT/HCPCS codes and modifiers.
Contact the Health Plan for clarifications on coverage, billing, or authorization processes.

Clinical Background and Evidence Basis

This clinical policy references contemporary evidence-based guidelines and peer-reviewed literature to inform the management of varicose veins and superficial venous reflux. It emphasizes use of duplex ultrasound for evaluation and considers endovenous treatments, including sclerotherapy and chemical endovenous ablation, consistent with recent society guidance on management of lower-extremity varicose veins.

Definitions and Key Concepts

inv-08: Superficial truncal reflux management — key guideline reference

Referenced guidelineJ Vasc Surg Venous Lymphat Disord. 2023;11(2):231-261.e6 — ‘Duplex Scanning and Treatment of Superficial Truncal Reflux’ endorsed by the Society for Vascular Medicine and the International Union of Phlebology.

ScopeManagement of varicose veins of the lower extremities with emphasis on duplex scanning and treatment of superficial truncal reflux.

Recommended diagnostic modalityDuplex ultrasound (duplex scanning) for evaluation of superficial truncal reflux prior to treatment.

Treatment focusEndovenous approaches for superficial truncal reflux as described in the guideline (endovenous ablation techniques).

EndorsementsEndorsed by the Society for Vascular Medicine and the International Union of Phlebology.